Telix Pharmaceuticals

TLX · NASDAQ

$9.15−$0.39 (−4.09%)TodayMarket closed ·
Prev close $9.54

TLX key statistics

Market cap
—
Price-earnings ratio
0.00
Dividend yield
—
Average volume
401.19K
Volume
413.45K
Open price
$9.26
High today
$9.30
Low today
$9.11
52 Week high
$13.11
52 Week low
$6.28

Telix Pharmaceuticals (TLX) at a glance

As of Oct 23, 2026, Telix Pharmaceuticals (TLX) shares are priced at $9.15, giving the company a price-to-earnings ratio of 0.00.

Today the stock has traded between $9.11 and $9.30. The current price is 0.4% above the day's low and 1.6% below its high.

Volume so far is 413.45K shares, in line with the average of 401.19K shares a day.

Over the past year Telix Pharmaceuticals has ranged from $6.28 to $13.11, and now sits 42% of the way up that range.

The average analyst price target is $0.00, 100.0% below the current price, from 3 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 3 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 1 analystsAvg $0.00
Low
$0.00
Now
$9.15
High
$0.00

TLX news

  • Avi Kapoor

    Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings

  • Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy

  • Avi Kapoor

    Crude Oil Down 4%; Intel Shares Move Higher

  • Vandana Singh

    Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse

  • Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'

  • Vandana Singh

    FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

  • 12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.